M

Milestone Scientific Inc
AMEX:MLSS

Watchlist Manager
Milestone Scientific Inc
AMEX:MLSS
Watchlist
Price: 0.3152 USD 8.69%
Market Cap: $25.4m

EV/EBIT

-4.5
Current
37%
Cheaper
vs 3-y average of -7.1

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-4.5
=
Enterprise Value
$23m
/
EBIT
$-5.7m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-4.5
=
Enterprise Value
$23m
/
EBIT
$-5.7m

Valuation Scenarios

Milestone Scientific Inc is trading above its industry average

If EV/EBIT returns to its Industry Average (19.2), the stock would be worth $-1.35 (527% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-536%
Maximum Upside
No Upside Scenarios
Average Downside
531%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple -4.5 $0.32
0%
Industry Average 19.2 $-1.35
-527%
Country Average 19.6 $-1.37
-536%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 8 638 companies
0th percentile
-4.5
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

Milestone Scientific Inc
Glance View

Market Cap
25.4m USD
Industry
Health Care

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 20 full-time employees. The firm is engaged in research and development that patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. The device, using The Wand, a single use disposable handpiece, is marketed in dentistry under the trademark CompuDent, and STA Single Tooth Anesthesia System and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in approximately 38 other countries. Its medical devices have obtained CE mark approval and can be marketed and sold in European countries.

MLSS Intrinsic Value
0.4906 USD
Undervaluation 36%
Intrinsic Value
Price $0.3152
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett